TP53 and prostate neoplasm: Consistently, Treg cells isolated from recipients harboring p53-deficient tumors displayed increased suppressive capacity compared to their WT counterparts, dovetailing with a similar observation in PTEN- and p53-null prostate tumors (Bezzi et al., 2018).